-Register now to attend Capitol Conference 2023! The conference is going to be held from February 26 to March 1 at the Hyatt Regency on Capitol Hill in Washington DC. Click here to register now.
-NABIP submitted a comment letter to CMS in response to the agency’s proposed 2024 Notice of Benefit and Payment Parameters. The draft NBPP includes major proposed provisions related to the door-to-door enrollment assistance by navigators and new regulations for agents and brokers.
-NABIP submitted a comment letter to HHS this week in response to a proposed rule titled “Confidentiality of Substance Use Disorder Patient Records.”
-In addition to the comment letters we submitted this week, NABIP responded to a request for information from CMS on essential health benefits under the ACA.
-Late last week, CMS announced a new 60-day special enrollment period for those who will lose coverage during the “Medicaid unwinding” this spring.
-Major drug manufacturers raised prices on 985 drugs during January, according to data from a drug-research nonprofit. All in all, the increases represent the most January hikes sought by manufacturers since at least 2011.
-The Texas Medical Association has filed its fourth lawsuit against the No Surprises Act, the section of the Consolidated Appropriations Act of 2021 that banned surprise billing.